BOUT — Innovator IBD(R) Breakout Opportunities ETF
Data updated: 2026-03-27
BOUT — Innovator IBD(R) Breakout Opportunities ETF data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Industrials Equity · $13.55M AUM · 0.80% expense ratio · -4.2% 1-yr return. From SEC regulatory filings.
BOUT Fund Overview
BOUT — Innovator IBD(R) Breakout Opportunities ETF is a US ETF managed by Innovator ETFs Trust, categorised as United States Industrials Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: Innovator ETFs Trust
- Category: United States Industrials Equity
- Assets under management: $13.55M
- 1-year return: -4.2%
- Ticker: BOUT
- SEC CIK: 0001415726
- SEC series ID: S000063057
- Share class ID: C000204535
BOUT Holdings
Top 10 holdings of Innovator IBD(R) Breakout Opportunities ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Mount Vernon Liquid Assets Portfolio, LLC | 23.22% |
| Sandisk Corp/DE | 4.32% |
| LivaNova PLC | 3.69% |
| Bilibili Inc | 3.62% |
| Amentum Holdings Inc | 3.59% |
| Medline Inc | 3.41% |
| Wayfair Inc | 3.36% |
| Legence Corp | 3.34% |
| VSE Corp | 3.22% |
| LB Pharmaceuticals Inc | 3.18% |
BOUT Portfolio Allocation
Asset-class allocation of Innovator IBD(R) Breakout Opportunities ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.9% |
| Cash & Equivalents | 23.4% |
BOUT Performance
Total returns for BOUT (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 6.6% |
| 1 year | -4.2% |
| 3 years (annualised) | 8.6% |
| 5 years (annualised) | 4.0% |
BOUT Risk Information
Risk metrics for BOUT, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 15.9%
BOUT Costs and Fees
BOUT costs about $80 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.80%
- Gross expense ratio: 0.80%
- Portfolio turnover: 1668%
- Brokerage commissions: 57.89 bps of average net assets (SEC N-CEN)
BOUT Cashflows
Over the 12 months to 2026-01, Innovator IBD(R) Breakout Opportunities ETF had net inflows of $79.13K, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-01 | $1.88M |
| 2025-12 | $0 |
| 2025-11 | $0 |
| 2025-10 | $0 |
| 2025-09 | $0 |
| 2025-08 | $0 |
BOUT Debt Constituents
No individual debt constituents are reported in Innovator IBD(R) Breakout Opportunities ETF's latest SEC N-PORT filing.
BOUT Prospectus and SEC Filings
Official Innovator IBD(R) Breakout Opportunities ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Industrials Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.